Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Title:ACKNOWLEDGEMENTS TO REVIEWERS (2016)
Volume: 10 Issue: 2
Author(s): .
Affiliation:
Export Options
About this article
Cite this article as:
. , ACKNOWLEDGEMENTS TO REVIEWERS (2016), Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) 2016; 10 (2) . https://dx.doi.org/10.2174/187221481002170518185930
DOI https://dx.doi.org/10.2174/187221481002170518185930 |
Print ISSN 1872-2148 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3334 |
8
Related Articles
-
Myogenic Properties of Brain and Cardiac Vessels and their Relation to Disease
Current Vascular Pharmacology Insulin, Thrombin, ERK1/2 Kinase and Vascular Smooth Muscle Cells Proliferation
Current Pharmaceutical Design The Fetal Origins of Obesity: Early Origins of Altered Food Intake
Endocrine, Metabolic & Immune Disorders - Drug Targets Soluble Epoxide Hydrolase, a Target with Multiple Opportunities for Cardiovascular Drug Discovery
Current Topics in Medicinal Chemistry Behcets Syndrome: Literature Review
Current Rheumatology Reviews Hyaluronic Acid as a Protein Polymeric Carrier: An Overview and a Report on Human Growth Hormone
Current Drug Targets Arterial Stiffness and Cardiovascular Drugs
Current Pharmaceutical Design Toward Greater Insights on Applications of Modeling and Simulation in Pregnancy
Current Drug Metabolism Myocardial Infarction after Rituximab Treatment for Rheumatoid Arthritis: Is there a Link?
Current Pharmaceutical Design Neuroinflammation: A Therapeutic Target of Cotinine for the Treatment of Psychiatric Disorders?
Current Pharmaceutical Design Polymorphism Gln27Glu of β2 Adrenergic Receptors in Patients with Ischaemic Cardiomyopathy
Current Vascular Pharmacology Targeting Metallothionein for Prognosis and Treatment of Breast Cancer
Recent Patents on Anti-Cancer Drug Discovery Advances in Quantitative Mass Spectrometry Analysis: Weighing in on Isotope Coding and Label-Free Approaches for Expression and Functional Proteomics
Current Analytical Chemistry S-Nitrosylation: Targets, Controls and Outcomes
Current Genomics The Stroke-Induced Blood-Brain Barrier Disruption: Current Progress of Inspection Technique, Mechanism, and Therapeutic Target
Current Neuropharmacology Histone Acetylation as a Potential Therapeutic Target in Motor Neuron Degenerative Diseases
Current Pharmaceutical Design Recent Advances in Validating MDM2 as a Cancer Target
Anti-Cancer Agents in Medicinal Chemistry Emerging Targets for the Treatment of Dyslipidemia
Current Medicinal Chemistry Targeting Transcription Factors for Cancer Therapy
Current Pharmaceutical Design D Allele Frequency in Insertion/Deletion Polymorphism of the Angiotensin Converting Enzyme (ACE) Gene is Associated with Development of Breast Cancer Risk in Indian Women
Current Proteomics